Aristotle Introduces Integrity FinAfford and Partnership With Department of Trust for Financial Risk Checks
16.1.2025 13:30:00 CET | ACCESS Newswire | Press release
WASHINGTON, D.C., WASHINGTON, D.C. / ACCESS Newswire / January 16, 2025 / Aristotle Integrity, the KYC and Identity division of Aristotle, is delighted to announce its partnership with the Department of Trust to deliver affordability checks and advanced diligence technology. This partnership addresses the needs of UK-regulated online gambling companies, which must comply with stricter UKGC responsible gambling requirements effective from 28th February 2025. From this date, online gambling operators are required to perform financial risk checks when a player's net deposits exceed £150 within a 30-day period - approximately 20% of online players. Additional due diligence is also mandated for higher spending or identified risks that warrant intervention.
John Aristotle Phillips, CEO of Aristotle, commented:
"The ability to integrate such a valuable technology like the Department of Trust's will further enhance our Integrity FinAfford™ product. By combining Aristotle's extensive history and performance in the regulated iGaming business for KYC with the Department of Trust's award-winning financial risk and vulnerability checks into a unified service, FinAfford provides an ideal solution for operators needing a seamless way to integrate and meet the rapidly approaching compliance deadline and beyond."
DoTrust CEO Charles Cohen added:
"We are thrilled to have been selected by Aristotle to enhance FinAfford™ with our comprehensive range of risk assessments. Aristotle holds a leading position in the global iGaming market and enjoys a strong reputation for customer focus and innovation. Through this partnership, we will deliver our uniquely compliant, accurate, and auditable risk assessments to more operators at this critical juncture."
Integrity FinAfford™, when combined with Aristotle's Integrity IDV product within the KYC process, simplifies player onboarding. FinAfford™ enables operators to conduct financial risk checks simultaneously, providing assessments and other key variables to operators, helping them determine deposit thresholds per player and reduce exposure to social responsibility challenges in the future. UK iGaming operators now have access to a combined product that facilitates setting initial player deposit limits and, as the player's activity increases, seamlessly meets higher diligence requirements.
Aristotle plans to extend its Integrity FinAfford™ product to Brazil, anticipating similar responsible iGaming affordability checks in this newly regulated market. Phillips added:
"Integrity has always been at the forefront of regulated iGaming markets, and supporting our partners in meeting their regulatory obligations is central to our technological development. As iGaming markets mature, regulatory bodies assess the political and social landscapes and adapt their requirements. We anticipate responsible gaming provisions becoming an integral part of regulations, and FinAfford™ is designed to help our partners meet these needs. In addition to Brazil, we are exploring the expansion of Integrity FinAfford's coverage to the United States."
About Aristotle Integrity Aristotle Integrity is a leader in identity and KYC solutions for regulated markets, providing innovative tools to ensure compliance and streamline operations. For more information, visit integrity.aristotle.com
About Department of Trust The Department of Trust is an award-winning provider of financial risk and vulnerability checks, offering cutting-edge solutions for responsible gaming and compliance. Learn more at dotrust.co.uk
Media Contact: Brandi Travis
CMO, Aristotle
press@aristotle.com
###
Contact Information
Brandi Travis
CMO
brandi.travis@aristotle.com
270-704-2462
SOURCE: Aristotle
View the original press release on ACCESS Newswire
Aristotle

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom